← Back
$SNDX All transactions

Syndax Pharmaceuticals Inc

J

$ Value

$10K

Shares

1,219

Price

$8

Filed

Feb 6

Insider

Name

Goldan Keith A.

Title

Chief Financial Officer

CIK

0001495411

Roles

Officer

Transaction Details

Transaction Date

2026-01-30

Code

J

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

93,671

Footnotes

The Reporting Person is voluntarily filing this Form 4 to report the acquisition of 1,219 shares by the Reporting Person on 1/30/2026 pursuant to the Issuer's Employee Stock Purchase Plan. | Award of restricted stock units ("RSUs"), representing the right to receive one share of Common Stock for each RSU. One third (1/3rd) of the shares of Common Stock subject to such RSU shall vest annually on the anniversary of the Vesting Commencement Date, during the Reporting Person's continued service as an employee, consultant, director or officer of the Company over the three (3) years following the date of grant, until all of the shares subject to such RSU are fully vested. | Award of RSUs, representing the right to receive one share of Common Stock for each RSU. The number of shares of Common Stock acquired upon vesting of the RSUs is contingent upon the achievement of pre-established performance metrics, as approved by the Company's Compensation Committee, subject to the Reporting Person's continued service as an employee, consultant, director or officer of the Company. | Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. | 1/48th of the shares subject to the option shall vest monthly over a four-year period.

Filing Info

Accession No.

0001193125-26-041497

Form Type

4

Issuer CIK

0001395937

Goldan Keith A.'s History

Date Ticker Type Value
2026-04-01 ABEO A $0
2026-02-09 SNDX $72K
2026-02-06 SNDX $43K
2026-02-04 SNDX A $0
2026-02-04 SNDX A $0
2026-02-04 SNDX A $2.4M
2026-01-30 SNDX J $10K
2025-12-01 SNDX G $0
2025-07-31 SNDX J $10K
2025-07-16 SNDX $12K

Other Insiders at SNDX (90d)

Insider Bought Sold Last
Podlesak Dennis 2026-02-04
Katkin Keith 2026-02-04
Legault Pierre 2026-02-04
Goldan Keith A.
Chief Financial Officer
$115K 2026-02-09
Metzger Michael A
Chief Executive Officer
$514K 2026-02-09
Huber Martin H. Jr. 2026-02-04
Jarrett Jennifer 2026-02-04
Rizo Aleksandra 2026-02-04
Botwood Nicholas A.J.
Head of R&D, CMO
2026-02-04